Skip to search formSkip to main contentSkip to account menu

NovoLog Mix 70/30

Known as: NovoLog Mix 70:30, NovoMix 30 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

insulin aspart, insulin aspart protamine drug combination 30:70

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Nondestructive Quantitative Inspection of Drug Products Using Benchtop NMR Relaxometry—the Case of NovoMix® 30
Batch-level inference-based quality control is the standard practice for drug products. However, rare drug product defects may be… 
2017
2017
Application of Premixed Insulin NovoMix®30 and NovoRapid® as Multiple Daily Injections or as Basal Bolus Format in Selected Diabetic Patients: Practical Evidence from Prospective Case Series
Managing type-1 or type-2 diabetes by insulin is one of the best techniques, especially for type-2 diabetics after oral… 
2016
2016
IDENTIFIKASI PENGGUNAAN OBAT PADA PASIEN DIABETES MELLITUS TIPE II USIA LANJUT DENGAN BEER’S CRITERIA DI INSTALASI RAWAT INAP RUMAH SAKIT IBNU SINA MAKASSAR PERIODE TAHUN 2012
U sing identif ication in the use medicine  with Beer 's C riteria to the advanced age patients in Inpatient installation in Ibnu… 
Review
2015
Review
2015
Detemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new case
BackgroundIn the first and only literature review, conducted in 2009, of human insulin analog- induced lipoatrophy, there were 12… 
2013
2013
W1428/13 Angående utsänd påstått bedräglig information kring prissänkning av insulinerna NovoRapid FlexPen, NovoMix FlexPen, Insulatard FlexPen, Levemir FlexPen
2010
2010
Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors
PurposeUnderstanding treatment satisfaction (TS) for diabetes is increasingly important as treatment options increase. This study… 
Review
2009
Review
2009
A PROSPECTIVE, OPEN-LABELLED, NON-CONTROLLED OBSERVATIONAL STUDY TO ASSESS DOCTOR PREFERENCE ON FLEXPEN™ FOR TREATMENT OF DIABETES MELLITUS
Background: The accuracy and convenience of pen devices for insulin injection have improved quality of life for patients with… 
2009
2009
Novomix® 30 hat bei dreimal täglicher Gabe ein vergleichbares Wirkprofil wie eine Basis-Bolus-Therapie mit den Analog-Insulinen Glargin und Glulisine
Highly Cited
2009
Highly Cited
2009
Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix® 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE…
Aims:  IMPROVE™ is an open‐label, multinational, non‐randomised, 26‐week observational study designed to evaluate the safety and… 
2009
2009
Significant Improvements in Glycaemic Control with BIAsp 30 in Clinical Reality: Experience from Clinical Practice in Macedonia
This was a prospective, multicenter, 24-week observational study of the effectiveness and safety of biphasic insulin aspart 30… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)